Guardant Health (GH) Enterprise Value (2017 - 2025)
Guardant Health (GH) has disclosed Enterprise Value for 9 consecutive years, with -$1.2 billion as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 43.05% to -$1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.2 billion through Dec 2025, down 43.05% year-over-year, with the annual reading at -$1.2 billion for FY2025, 43.05% down from the prior year.
- Enterprise Value hit -$1.2 billion in Q4 2025 for Guardant Health, down from -$580.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$580.0 million in Q3 2025 to a low of -$1.9 billion in Q1 2021.
- Historically, Enterprise Value has averaged -$1.1 billion across 5 years, with a median of -$960.2 million in 2022.
- Biggest five-year swings in Enterprise Value: crashed 296.35% in 2021 and later soared 50.72% in 2022.
- Year by year, Enterprise Value stood at -$932.7 million in 2021, then fell by 8.41% to -$1.0 billion in 2022, then fell by 15.57% to -$1.2 billion in 2023, then grew by 28.12% to -$840.0 million in 2024, then plummeted by 43.05% to -$1.2 billion in 2025.
- Business Quant data shows Enterprise Value for GH at -$1.2 billion in Q4 2025, -$580.0 million in Q3 2025, and -$629.1 million in Q2 2025.